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Abstract
In order to analyse structures of proteins of a particular class, these need to be extracted
from Protein Data Bank (PDB) files. In the case of antibodies, there are a number of spe-
cial considerations: (i) identifying antibodies in the PDB is not trivial, (ii) they may be crys-
tallized with or without antigen, (iii) for analysis purposes, one is normally only interested
in the Fv region of the antibody, (iv) structural analysis of epitopes, in particular, requires
individual antibody–antigen complexes from a PDB file which may contain multiple cop-
ies of the same, or different, antibodies and (v) standard numbering schemes should be
applied. Consequently, there is a need for a specialist resource containing pre-numbered
non-redundant antibody Fv structures with their cognate antigens. We have created an
automatically updated resource, AbDb, which collects the Fv regions from antibody
structures using information from our SACS database which summarizes antibody struc-
tures from the PDB. PDB files containing multiple structures are split and numbered and
each antibody structure is associated with its antigen where available. Antibody struc-
tures with only light or heavy chains have also been processed and sequences of anti-
bodies are compared to identify multiple structures of the same antibody. The data may
be queried on the basis of PDB code, or the name or species of the antibody or antigen,
and the complete datasets may be downloaded.
Database URL: www.bioinf.org.uk/abs/abdb/
Introduction
As well as their role in the immune system, since an anti-
body was first administered to a human as a drug in 1986,
the field of therapeutic antibody development has grown
enormously. Antibody therapeutics now represent one
third of drugs in development, being used in a range of dis-
eases from infection to cancer (1). Antibodies are capable
of binding with high specificity and affinity and, unlike
small molecule drugs, are able to bind large flat surfaces
rather than pockets. Their importance in biomedical re-
search, diagnostics and therapeutics (2) has led to a need to
understand the basis of antibody specificity, binding affin-
ity, stability and structure. A number of databases contain
antibody sequence data (3–9), while others provide sum-
maries of, or access to, structural data (6, 7, 9, 10, 11). In
the Protein Data Bank (PDB), managed by the Worldwide
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PDB (wwPDB) (12) antibody structures currently represent
2.1% of entries (January 2018).
There are a number of resources that make information
about antibody structures available. The first of these was
SACS (10) which simply provides a regularly-updated list
of antibody structures from the PDB with some basic anno-
tations. abYsis (6) is predominantly an analysis resource; it
brings together antibody sequence data from different pub-
licly available data sources including Kabat, EMBL-ENA,
the PDB and, optionally, IMGT, providing tools to analyse
antibodies within the web-based resource (e.g. numbering
(13), canonicals (14, 15), unusual residues, humanness
(16), germline source, etc.). IMGT/3Dstructure-DB (7)
provides an interface for the inspection of antibody struc-
ture data including bound protein antigens. SAbDab (11)
provides a web-based search interface and allows the origi-
nal antibody PDB files to be downloaded, as well as PDB
files with Chothia numbering applied. These numbered
files also contain information about the pairing of light
and heavy chains and identify associated antigen chains.
For the purposes of this paper, we use the term ‘anti-
body’ to refer to antibody-derived antigen binding frag-
ments including light-chain dimers and camelid VHHs
(isolated variable heavy chains). Thus the relationship be-
tween antibody and antigen chains in a PDB file is com-
plex. Antibodies may consist of a light-chain dimer, a
single heavy chain or a conventional light/heavy complex.
Likewise, antigens may consist of small molecules or of
one or more protein or non-protein chains and the epitope
to which an antibody binds may span more than one chain.
A single PDB file may contain multiple copies of the same
antibody or multiple antibodies bound to different parts of
the same antigen. Figure 1 provides an entity-relationship
(ER) diagram describing these scenarios.
Antigens having multiple chains have proved a particu-
lar challenge for the analysis of discontinuous epitopes that
span multiple antigen chains and some studies have simply
excluded such examples from the analysis (17). Another
problem with antibody structure related resources is the in-
correct identification of ‘antibody-binding proteins’ as
antigens. As a result, epitopes and paratopes, such as those
identified by IMGT/3Dstructure-DB, can be incorrect. For
example, PDB file 1DEE (18), contains a complex between
the Fab fragment (antigen-binding fragment) of IgM anti-
body 2A2 and Ig-binding domain D of the Staphylococcus
aureus virulence factor, protein A (SpA). SpA binds
to framework residues of the VH (heavy variable) domain
that are highly conserved in human VH3 germline derived
domains; the complementarity determining regions
(CDRs) are not involved. Both IMGT/3Dstructure-DB and
SAbDab erroneously indicate that this antibody is in a
complex with antigen. In addition, antibodies themselves
can act as antigens; other antibodies can bind to the frame-
work, or so-called anti-idiotypic antibodies can bind the
CDRs. When an antibody binds to the framework there is
a clear differentiation between antibody and antigen. In
the case of anti-idiotypic complexes, without additional in-
formation, it is impossible to determine which is truly the
antibody and which is the antigen.
We set out to develop an automatically maintained re-
source to address these and other problems. In particular
we wished our resource to:
• Correctly identify antibody-binding proteins and not
treat them as antigens,
• Provide downloadable isolated Fv (variable) fragments
discarding constant domains,
• Provide multiple numbering schemes [Kabat (19),
Chothia (20) and Martin (13)],
• Split PDB files containing multiple antibodies into sepa-
rate files, each containing antigen chains as appropriate.
For example, PDB file 4FQR contains 12 copies of the
same antibody and these need to be split into separate
files; in 3ULU, three different antibodies are bound to
the same antigen chain so this must be replicated be-
tween the three files,
• Correctly handle cases where the antibody binds multiple
chains of an antigen (e.g. 2FEE, 3PJS, 3ZTN),
• Deal with instances of anti-idiotypic antibodies where
each antibody is treated both as antibody and as antigen,
Figure 1. A PDB file may have single or multiple antibody–antigen (Ab/
Ag) sets. The notation is in Information Engineering Style: a single line
indicates one item; two lines indicates exactly one mandatory item; a
single line and a circle represents zero or one item; a crowsfoot with a
circle indicates zero or more items; a crowsfoot with a line indicates
one or more mandatory items. Each Ab/Ag Set contains exactly one an-
tibody. An antibody may be ‘complete’ (containing one light and one
heavy chain), or may be a light-chain dimer or heavy-chain monomer.
Each Ab/Ag Set also contains zero or one antigen which contains one or
more molecules or chains. Note that the same antigen may take part in
more than one Ab/Ag Set.
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• Provide information on redundancy (representative anti-
bodies and lists of non-redundant antibodies and redun-
dant sets),
• Provide information on antibodies that are available
both bound and unbound,
• Provide separate datasets for antibody–antigen com-
plexes where the antigen is a protein and where it is a
non-protein (e.g. PDB code 4M7J binds carbohydrate,
1A0Q and 1BAF bind hapten, 3VW3 binds DNA and
2R8S binds RNA),
• Correctly handle light-chain-only antibodies (such as
Bence-Jones dimers) and heavy-chain-only (VHH)
antibodies,
• Provide a dataset that is as clean and robust as possible,
potentially at the expense of excluding a small percent-
age of the available structures,
• Provide a web interface that can be used to search by
PDB code, antibody or antigen name or species, but most
importantly allows the download of complete datasets of
free antibodies, antibodies complexed with protein anti-
gens or antibodies complexed with non-protein antigens,
as well as lists of redundant antibodies and complexed/
uncomplexed pairs. In addition, we wished to separate
‘complete’ antibodies (i.e. paired light and heavy chains),
light-chain dimers and heavy-chain-only structures.
To our knowledge, none of the other available resources
deals with all these problems.
Materials and Methods
Data processing pipeline
PDB data are mirrored locally and automatically uncom-
pressed using ftpmirror which may be obtained from
github.com/AndrewCRMartin/bioscripts. Identification of
antibody structures in the PDB is not trivial because they
may be described as ‘antibody’ or ‘immunoglobulin’ and
both keywords may be used in other contexts; without
further precautions, simple homology searches will also
identify related molecules such as T-cell receptors.
Identification of antibody PDB files is handled by an en-
hanced version of the SACS procedure described previously
(10). SACS data were obtained as an XML file from www.
bioinf.org.uk/abs/sacs/ and parsed to obtain a list of PDB
codes.
Figure 2 shows a work flow diagram, for which the ma-
jor processing steps are explained in detail below.
Step 1: Identify Chain Types. Each PDB file is processed
to identify the chain types present: light, heavy or antigen.
An in-house program, idabchain, also used by SACS (10),
aligns the sequence of each PDB chain with consensus
light- and heavy-chain variable domain sequences. Each
chain is provisionally assigned as light or heavy depending
which scores higher and the highest score is recorded. Each
chain that was provisionally identified as light (respectively
heavy) in the previous step is then reassigned as antigen if
it does not have the highest score for a match against the
light (respectively heavy) chain sequence (i.e. other chains
score more highly) and its score is <80%. If SEQRES
records are available, then the sequence is read from both
the SEQRES and ATOM records and the higher score is
selected—this deals with missing residues in ATOM
records and also cases where the SEQRES records contain
the leader sequence the signal sequence present at the
N-terminus of immature antibodies.
Step 2: Assign antibody type. A decision is then made as
to whether the antibody is ‘complete’ (containing both
light and heavy chains), light-chain only or heavy-chain
only. Complete antibodies and antibodies containing a sin-
gle chain type are then processed differently to deal with
Figure 2. Data processing algorithm outline. The circled numbers refer
to steps in the text and the shaded boxes are the output datasets.
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correct chain pairing. In particular, for some cases of light-
chain-only antibodies, the symmetry of the two light chains
means that only one chain appears in the original PDB file.
pdbsymm from BiopTools (21) exploits the REMARK 350
BIOMT records to construct a new PDB file containing the
two copies of the light chain.
Step 3: Splitting and Numbering. In a PDB file, peptide,
protein, DNA and RNA antigens are present as ATOM
records with distinct chain labels whereas lipid, carbohy-
drate and hapten antigens are represented by HETATM
records and may have the same chain label as one of the
protein chains. The file is then split such that each chain
(as defined by the chain label in the PDB file) is placed in
its own file and associated HETATMs are removed to be
handled later. The files containing the antibody chains are
then numbered according to each of the three numbering
schemes (Kabat, Chothia and Martin) using Abnum (13)
and constant domains are discarded.
Step 4: Antibody Reassembly. Most PDB files contain-
ing ‘complete’ antibodies have either duplets of light and
heavy chains, or triplets of light, heavy and antigen chains
which appear in that order (i.e. light, heavy or light, heavy,
antigen). However, this is by no means always the case.
Even the presence of L and H chain labels does not always
indicate a pair of light and heavy chains forming an anti-
body. It is therefore necessary to determine the correct
pairs of light and heavy chains from the chain type assign-
ments in the split chains. For heavy-chain-only antibodies,
no antibody chain pairing needs to be performed. Light-
chain-only antibodies require the two light chains (gener-
ated by symmetry if necessary) to be paired and this is
done by identifying chains having the Ca of residue L36
(light chain residue 36 using Kabat numbering) in the two
chains within 20 A˚ of one another and the Ca of the two
L87 residues also within 20 A˚. For ‘complete’ antibodies,
chains are paired where there is a maximal number of con-
tacts defined as having atom centres within 4 A˚. For exam-
ple, PDB file 1DVF (Figure 3) is an anti-idiotypic antibody
with light chains A, C and heavy chains B, D. Light chain
A makes 128 contacts with heavy chain B and 20 contacts
with heavy chain D. Light chain C makes 10 contacts with
heavy chain B and 117 with heavy chain D. Consequently
one antibody is formed from chains A, B while the other is
formed from chains C, D.
Step 5: Assigning Antibody/Antibody Complexes.
Initially antibodies in PDB files containing no non-
antibody chains (i.e. PDB files containing only light and
heavy chains) are assigned as free antibodies. However, if
the PDB file contains more than one antibody, it is possible
that one is acting as an antigen for the other. If the sequen-
ces of the two antibodies are identical then this will not be
the case, but if the sequences are different then they will be
forming antibody–antigen pairs (e.g. PDB entry 1DVF,
Figure 3). Thus each antibody in turn is reassigned as being
a potential 2-chain antigen and processed as such in the
next steps. All such antibodies are placed in the protein an-
tigen set.
Step 6: Assigning Free/Complexed Antibodies for
HETATM Complexes. If an antibody is currently assigned
as uncomplexed, a check is now made for CDR contacts
with HETATM non-protein antigens including haptens,
lipids and carbohydrates which were previously removed
from the PDB files. These groups are assigned as antigen if
there are inter-atom contacts of <4 A˚ between any pairs of
atom centres, but there are no CONECT records indicating
that the HETATM group is covalently bound to the anti-
body. All such antibody complexes are placed in the non-
protein antigen set.
Step 7: Assigning Free/Complexed Antibodies for
Protein and Nucleotide Antigens. Antibodies from PDB
files containing non-antibody chains (protein, DNA or
RNA) are initially assumed to be complexes. However, the
correct antigen chain must be identified and, in some cases,
while the non-antibody protein is indeed contacting the an-
tibody, it is not interacting with the CDRs of the antibody
and should therefore be classified as an antibody-binding
protein rather than as an antigen as described for PDB file
1DEE. A non-antibody chain is identified as antigen based
on the following conditions: (i) more contacts are made
with CDRs than with framework and (ii) at least 15 con-
tacts are made with the CDRs. Again, contacts are defined
as a distance of  4A˚ between any pair of atom centres.
Antibodies can bind across antigens which have multiple
chains. For example, in 4XI5, the antibody binds to chains
L and H from the envelope glycoprotein of Varicella zoster
virus (22).
Figure 3. An example of an anti-idiotype antibody where one antibody
is interacting with the CDRs of another antibody. The processing pipe-
line generates two structures with each antibody treated as antibody
and antigen, respectively (PDB entry: 1DVF).
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Step 8: Annotating the PDB files. The bulk of the stan-
dard PDB header is removed and replaced by customized
REMARK 950 records (not used by the wwPDB in PDB
files). During numbering of the antibody chains, the chain
labels are replaced by L and H as appropriate. A
REMARK 950 record is used to indicate the mapping of
the L and H chains to their original chain labels in the
source PDB file. Antigen chains will retain their original
chain label unless an antigen had the original label L or H,
in which case it will be replaced by lowercase l or h, respec-
tively. Other key annotations provided in the REMARK
950 records include: the numbering scheme applied to the
antibody structure; the method by which the structure was
solved; the resolution, R-factor, and R-Free where appro-
priate; and the antigen and antibody molecule name and
species.
Antibodies binding to DNA or RNA antigen chains are
added to the non-protein antigen set while others are
placed in the protein antigen set. Note that some of the
PDB files contain both free and complexed antibodies. The
above procedure handles this, separating antibody–antigen
complexes and free antibodies into their respective data-
sets. At this stage, the pipeline has segregated the data into
three antibody types: (i) complete antibodies (heavy and
light chains), (ii) light-chain-only antibodies and (iii)
heavy-chain-only antibodies. Each of these types is sub-
divided into three complex classes: (i) free antibodies,
(ii) complexes with protein and (iii) complexes with non-
protein (DNA, RNA, hapten, lipid or carbohydrate). Each
of these 9 datasets is numbered with 3 numbering schemes
making 27 separate datasets. In addition, another nine
datasets are generated for the three antibody types and
three numbering schemes, but with each set containing all
three complex classes.
Thus, 36 datasets are made available, but at this stage
many of the antibodies may be ‘redundant’—i.e. the same
antibody appears in several files (originating from either
the same PDB file or different files) and may be present
both complexed and uncomplexed.
Redundancy processing
In order to provide information about redundant antibod-
ies, the ATOM records of the numbered antibody struc-
tures are used to extract the sequence. Each antibody pair
(both light and heavy chains) is compared on the basis of
the residue labels that are present in both sequences. For
example, if residue L24 is present in both sequences and
the amino acid is different, then the two antibodies would
not be regarded as redundant. If residues are missing in
one antibody compared with the other, these positions are
ignored in the comparison. This process is repeated across
all pairs of antibodies in order to identify redundant
clusters.
In order to select a representative from each cluster, if
there were differences in lengths, then the shorter sequen-
ces are discarded. From the remaining structures, the high-
est resolution structure is selected.
The non-redundancy processing is performed across
each of the 36 (redundant) datasets described previously
such that a non-redundant dataset is produced for each of
the redundant sets.
In addition, lists are generated indicating the redundant
clusters. A total of 12 lists are provided for each of the
three antibody types (complete, light-chain-only and
heavy-chain-only) and each of the four complex classes:
(free, protein, non-protein, all). In addition, three more
lists are provided for antibodies available both free and
complexed (for each antibody type: complete, light-chain-
only and heavy-chain-only).
Implementation
The system is completely automatic and is implemented
in Perl, C and Bash. The main data processing algorithm
is implemented in Perl. It extracts PDB codes from the
SACS XML file, does all the processing [including calling
out to Abnum (13) to perform the numbering] and
generates separate directories for each dataset of
antibody structures. In-house programs to identify anti-
body chains (idabchain) and haptens (hashapten) and the
Abnum numbering program are written in C. The web
page is generated automatically to provide access




The data are available via a web interface at www.bioinf.
org.uk/abs/abdb/. RESTful web services access to the data-
files is also provided via the web site.
Database searching
The resource may be searched by PDB code, keyword (an-
tibody or antigen name) and species (of antibody or anti-
gen). The results are presented as a table with all the
antibodies that match the search query along with any
antibodies that are redundant with these antibodies. The
information in the table includes a downloadable antibody
structure file for each of the three numbering schemes
(Kabat, Chothia and Martin), the antibody status (free or
complexed), resolution and R-factor.
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PDB files containing antibody–antigen complexes can con-
tain multiple antibody structures (which may or may not be
identical sequences) and the main processing pipeline will
have split these into separate files. For example, 1AFV con-
tains two copies of the same antibody, FAB25.3, bound to
two copies of the human immunodeficiency virus type 1 cap-
sid protein (Figure 4a). The main processing pipeline identi-
fies chains L and H as one antibody, chains K and M as a
second antibody and identifies chain A as the antigen associ-
ated with the first antibody and chain B as associated with
the second antibody. The Fv region of the first antibody
(chains L, H) together with its cognate antigen (chain A) is
stored as as 1AFV_1 while the Fv of the second antibody and
its antigen (chains K, M, B) is stored as 1AFV_2. While
1AFV only contains ‘internal redundancy’ (i.e. there are two
copies of FAB25.3 in the original PDB file, but no other files
contain a structure for FAB25.3), some antibodies are present
in multiple PDB files. For example, a search for PDB 4KKC
will display the two copies (4KKC_1 and 4KKC_2) that are
present in that PDB file together with an additional 72 PDB
entries having the same antibody sequence.
On the other hand, 3ULU contains three different anti-
bodies (FAB15, FAB12 and FAB1068) bound to different
parts of the same antigen (human toll-like receptor 3—
chain A in the PDB file) as shown in Figure 4b. Thus the
main processing pipeline generates three files, each con-
taining a copy of the antigen and one of the antibodies:
3ULU_1 (containing chains L, H and A), 3ULU_2 (chains
C, D and A) and 3ULU_3 (chains E, F and A). In such
cases, redundant antibody information is provided for each
of the distinct antibodies (Table 1).
In addition to the search by PDB code, the database can
be queried by a keyword from the antibody or antigen name.
For example, all the structures for the HyHEL antibodies
(anti-hen egg white lysozyme) from the Smith-Gill group (23)
can be queried using ‘hyhel’. Similarly, all the capsid-antigen-
bound antibodies can be queried by searching for ‘capsid’.
Data can also be searched by antibody and antigen species
and a drop-down menu has been provided with all the species
of antibody and antigen observed in the dataset.
Data download
As well as individual PDB files, a compressed archive of
each of the 72 antibody structures datasets (the 36 redun-
dant and 36 non-redundant sets described above) can be
downloaded. In addition, the following information can be
downloaded: (i) the 12 lists of redundancy information—
one for each of the three antibody types (complete, light-
chain-only and heavy-chain-only) and each of the four
complex classes (free, protein, non-protein, all); (ii) three
lists of antibodies (one for each type: complete, light-
chain-only and heavy-chain-only) that are available both
free and complexed and (iii) a list of mappings between
chains for each antibody/antigen complex and the chain
Figure 4. (a) PDB file 1AFV containing two copies of the same antibody (chains H/L and K/M) complexed with two copies of the same antigen (chains A and
B), (b) PDB file 3ULU containing three different antibodies (chains C/D, E/F and L/H) interacting with different parts of the same antigen (chain A).
Table 1. Non-redundant antibodies in PDB file 3ULU along
with other redundant antibody structures





3ULU_1 Protein complex 3ULV_1 Protein complex
3NA9_1 Non-protein complex
3ULU_2 Protein complex 3ULV_2 Protein complex
3ULS_1 Free antibody
3ULS_2 Free antibody
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identifiers in the original PDB files for people wishing to
obtain the full Fab fragments from the original files.
Database statistics
A list of 2918 antibody structure PDB codes was obtained
from SACS. Of these, 2542 PDB files were successfully
processed to generate 4300 PDB files: 3731 complete anti-
bodies, 144 light-chain-only and 425 heavy-chain-only. A
detailed breakdown of the content of the AbDb database
as of October 2017 is shown in Table 2.
The SACS database which provides lists of antibodies to
be processed by AbDb is a cumulative resource (listing PDB
files that have now been obsoleted) that also contains infor-
mation on structures of antibody Fc fragments. Consequently
there are a number of files that are not processed by AbDb:
179 Fc fragments and 4 obsoleted. In addition, the numbering
procedure fails for at least 1 of the chains in 119 PDB files
and 65 files are identified as containing single chain Fvs
(scFvs) with a single chain label for the heavy- and light-
chain-derived parts of the sequence. scFvs are fused VH (vari-
able heavy) and VL (variable light) domains with a peptide
linker (24). Frequently the peptide linker is flexible and is not
visible in the PDB file and, in these cases, while part of a sin-
gle chain, the PDB file often has different chain labels for the
VH and VL regions. Such examples are processed correctly by
AbDb. However, in cases where the two regions have been
given the same chain label, the Abnum program is currently
not able to separate the two regions and therefore does not
number the protein correctly. Consequently these files are
currently automatically rejected.
Discussion
AbDb provides a valuable resource for the structural
immunologist, collecting pre-numbered structures of Fv
fragments together with their cognate antigens where
available. We have used this resource for a number of
applications including assessment of antibody modelling,
analysis of the variation in loop conformation on antigen
binding and analysis of epitope conformation (Ferdous and
Martin, in preparation). An earlier version was used for
the analysis of the packing between the two variable
domains (VH and VL) (25).
AbDb provides a regularly updated resource with proc-
essed antibody structures and has a number of features not
provided by other antibody structure resources. In particu-
lar, it provides:
• Processed PDB files containing only the variable domains
and split into individual antibodies with cognate antigens
(including multi-chain and non-protein antigens),
• PDB files numbered with Kabat, Chothia and Martin
numbering schemes,
• A total of 36 simply classified downloadable datasets:
complete antibodies, light-chain-only and heavy-chain-
only, also split into free antibodies, complexes with pro-
tein antigens and complexes with non-protein antigens
(all numbered with all three numbering schemes),
• Non-redundant versions of each of the 36 datasets,
• A total of 12 information files describing redundant
clusters,
• Information on redundancy when searching by PDB
code: a list of all processed PDB files containing redun-
dant antibodies is provided,
• Three information files describing antibodies available
both complexed and uncomplexed,
• Non-antibody proteins, not interacting predominantly
with the CDRs, are not treated as antigen and the anti-
body is classified as uncomplexed (e.g. 1DEE),
• Antibodies involved in anti-idiotype interactions are clas-
sified both as antibodies and antigens,
• Light-chain dimers regenerated by exploiting symmetry
information from the PDB file.
Table 2. Contents of the AbDb datasets, October 2017
Datasets Complex type Processed PDB files Resultant antibodies Non-redundant antibodies
Complete antibody Protein 1225 2067 866
Non-protein 353 493 244
Free antibody 688 1171 623
Complete dataset 2228 3731 1476
Light chains Protein 6 7 4
Non-protein 14 20 7
Light only 76 117 50
Complete dataset 96 144 57
Heavy chains Protein 149 280 118
Non-protein 9 16 9
Heavy only 68 129 66
Complete dataset 218 425 177
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Unfortunately it is almost impossible to predict every
variant of antibody structures that may become available
in the future. Consequently AbDb is continuously being
updated to handle unforeseen circumstances as they are en-
countered. The desire is to make the dataset clean and ro-
bust at the possible expense of missing some of the
available structures. Future planned enhancements include
improved processing of scFvs (single chain variable frag-
ments) and single chain Fabs (scFabs) where a single chain
label is used for light and heavy chain segments in the PDB
file. Currently, our idabchain program which identifies
chain types identifies these as hybrid chains, but the AbDb
pipeline does not process them further owing to current
restrictions in the numbering program Abnum. We there-
fore intend to improve Abnum to deal correctly with these
examples. While we have not yet encountered any struc-
tures, antibody drugs have been created having scFvs fused
to the C-terminus of a conventional heavy chain; AbDb
would currently ignore the scFv fusion and we need to cre-
ate a general method for dealing with fusions. Abnum has
been designed to fail cleanly with unusual structures rather
than provide incorrect numbering, but we plan to enhance
its ability to number these unusual cases. Similarly, the
symmetry information provided in the PDB file has only
been exploited for light-chain-only antibodies, but in fu-
ture will be expanded to handle all structures to ensure
that we use biological assemblies.
The PDB file format is officially deprecated, but still
widely used in structural bioinformatics. Future versions of
AbDb will add support for the newer mmCIF and PDBML
format files. In addition, the wwPDB has recently an-
nounced that the current four-character PDB code will be
replaced by an eight-character PDB identifier together with
a version number. AbDb will need to be modified to sup-
port this new format. Plans to enhance the web server in-
clude the addition of an integrated graphical viewer and
additional RESTful access to the data.
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